St. Joseph's Hospital Cancer Institute, 3001 Martin Luther King Jr. Blvd, Tampa, FL 33607-6307, USA.
Int J Oncol. 2012 Feb;40(2):305-49. doi: 10.3892/ijo.2011.1248. Epub 2011 Nov 4.
In some inflammasomes tumor cells are generated. The internal environment of the inflammasome is conducive to the induction of malignant transformation. Epigenetic changes initiate this process. The subverted stromal connective tissue cells act to promote and sustain the process of malignant trans-formation. In its early stages, the premalignant cells depend on paracrine circuitries for the reception of growth factors. The ligands are derived from the connective tissue, and the receptors are expressed on the recipient premalignant cells. The initial events are not a direct attack on the proto-oncogenes, and thus it may be entirely reversible. Epigenetic processes of hypermethylation of the genes at the promoters of tumor suppressor genes (to silence them), and deacetylation of the histones aimed at the promoters of proto-oncogenes (to activate them) are on-going. A large number of short RNA sequences (interfering, micro-, short hairpin, non-coding RNAs) silence tumor suppressor genes, by neutralizing their mRNAs. In a serial sequence oncogenes undergo amplifications, point-mutations, translocations and fusions. In its earliest stage, the process is reversible by demethylation of the silenced suppressor gene promoters (to reactivate them), or re-acetylation of the histones of the oncogene promoters, thus de-activating them. The external administration of histone deacetylase inhibitors usually leads to the restoration of histone acetylation. In time, the uncorrected processes solidify into constitutive and irreversible gene mutations. Some of the pathogens inducing inflammations with consquential malignant transformation contain oncogenic gene sequences (papilloma viruses, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, hepatitis B and C viruses, Merkel cell polyoma virus, Helicobacter pylori, enterotoxigenic Bacteroides fragilis). These induced malignancies may be multifocal. Other pathogens are devoid of any known oncogenic genomic sequences (mycoplasma vav-carcinogenesis, chlamydia MALT-lymphoma genesis). In these cases the host's inflammatory reactions induce the malignant transformation in serial sequences of gene alterations initiated by hypoxia and reactive oxygen and nitrogen species generation. Carcinogenic intrinsic inflammatory processes endogenously initiated without a pathogen are recognized. Chronic inflammatory processes signal the RNA/DNA complex. In response, the DNA may revert into its ancient primordial 'immortal' format, which the clinics recognize as 'oncogenesis'. The DNA remains the ultimate master of bioengineering in order to sustain life. A discussion on the most versatile and resistant primordial RNA/DNA complex and the pre-, proto-, and unicellular world in which they co-existed is included.
在某些炎性小体中会产生肿瘤细胞。炎性小体的内部环境有利于恶性转化的诱导。表观遗传变化启动了这个过程。被颠覆的基质结缔组织细胞起到促进和维持恶性转化过程的作用。在早期,前恶性细胞依赖旁分泌通路接收生长因子。配体来源于结缔组织,受体表达在前恶性细胞上。最初的事件并不是对原癌基因的直接攻击,因此它可能是完全可逆的。肿瘤抑制基因启动子的基因 hypermethylation(沉默它们)和组蛋白去乙酰化针对原癌基因的启动子(激活它们)的表观遗传过程正在进行。大量短 RNA 序列(干扰、微、短发夹、非编码 RNA)通过中和其 mRNA 来沉默肿瘤抑制基因。在一系列序列中,癌基因经历扩增、点突变、易位和融合。在其早期阶段,通过沉默的抑制基因启动子的去甲基化(重新激活它们),或癌基因启动子的组蛋白的再乙酰化,从而失活它们,这个过程是可逆的。组蛋白去乙酰酶抑制剂的外部给药通常会导致组蛋白乙酰化的恢复。随着时间的推移,未纠正的过程固化为组成型和不可逆的基因突变。一些诱导炎症并导致恶性转化的病原体含有致癌基因序列(乳头瘤病毒、Epstein-Barr 病毒、卡波西肉瘤相关疱疹病毒、乙型肝炎和丙型肝炎病毒、Merkel 细胞多瘤病毒、幽门螺杆菌、产肠毒素脆弱拟杆菌)。这些诱导的恶性肿瘤可能是多灶性的。其他病原体没有任何已知的致癌基因组序列(支原体 vav-致癌发生、衣原体 MALT-淋巴瘤发生)。在这些情况下,宿主的炎症反应通过缺氧和活性氧和氮物种的产生,诱导基因改变的串行序列,引发恶性转化。内源性启动的致癌固有炎症过程无需病原体即可识别。慢性炎症过程发出 RNA/DNA 复合物的信号。作为回应,DNA 可能恢复到其古老的原始“不朽”形式,临床将其识别为“致癌”。为了维持生命,DNA 仍然是生物工程的最终主宰。讨论了最通用和最具抗性的原始 RNA/DNA 复合物以及它们共存的前、原核和单细胞世界。